A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study

NCT05934331 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

276

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Neoplasms of Digestive Organs

Interventions

DRUG: LM-302
DRUG: Toripalimab
DRUG: Capecitabine
DRUG: Tegafur, Gimeracil and Oteracil Potassium Capsules
DRUG: Nivolumab
DRUG: Apatinib
DRUG: Gemcitabine

Sponsor

LaNova Medicines Zhejiang Co., Ltd.